| UniProt ID | RS19_HUMAN | |
|---|---|---|
| UniProt AC | P39019 | |
| Protein Name | 40S ribosomal protein S19 | |
| Gene Name | RPS19 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 145 | |
| Subcellular Localization | Nucleus . Located more specifically in the nucleoli. | |
| Protein Description | Required for pre-rRNA processing and maturation of 40S ribosomal subunits.. | |
| Protein Sequence | MPGVTVKDVNQQEFVRALAAFLKKSGKLKVPEWVDTVKLAKHKELAPYDENWFYTRAASTARHLYLRGGAGVGSMTKIYGGRQRNGVMPSHFSRGSKSVARRVLQALEGLKMVEKDQDGGRKLTPQGQRDLDRIAGQVAAANKKH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 | Ubiquitination | -MPGVTVKDVNQQEF -CCCCCCCCCCHHHH | 46.74 | - | |
| 7 | Succinylation | -MPGVTVKDVNQQEF -CCCCCCCCCCHHHH | 46.74 | 23954790 | |
| 23 | Succinylation | RALAAFLKKSGKLKV HHHHHHHHHHCCCCC | 38.14 | 23954790 | |
| 23 | Ubiquitination | RALAAFLKKSGKLKV HHHHHHHHHHCCCCC | 38.14 | - | |
| 23 | 2-Hydroxyisobutyrylation | RALAAFLKKSGKLKV HHHHHHHHHHCCCCC | 38.14 | - | |
| 23 | Malonylation | RALAAFLKKSGKLKV HHHHHHHHHHCCCCC | 38.14 | 26320211 | |
| 23 | Acetylation | RALAAFLKKSGKLKV HHHHHHHHHHCCCCC | 38.14 | 19608861 | |
| 27 | Acetylation | AFLKKSGKLKVPEWV HHHHHHCCCCCCHHH | 52.83 | 26051181 | |
| 29 | Acetylation | LKKSGKLKVPEWVDT HHHHCCCCCCHHHHH | 60.26 | 26051181 | |
| 29 | Malonylation | LKKSGKLKVPEWVDT HHHHCCCCCCHHHHH | 60.26 | 26320211 | |
| 29 | Ubiquitination | LKKSGKLKVPEWVDT HHHHCCCCCCHHHHH | 60.26 | 21890473 | |
| 29 | 2-Hydroxyisobutyrylation | LKKSGKLKVPEWVDT HHHHCCCCCCHHHHH | 60.26 | - | |
| 38 | Acetylation | PEWVDTVKLAKHKEL CHHHHHHHHHHCCCC | 44.83 | 26051181 | |
| 38 | Ubiquitination | PEWVDTVKLAKHKEL CHHHHHHHHHHCCCC | 44.83 | 21906983 | |
| 38 | 2-Hydroxyisobutyrylation | PEWVDTVKLAKHKEL CHHHHHHHHHHCCCC | 44.83 | - | |
| 43 | Acetylation | TVKLAKHKELAPYDE HHHHHHCCCCCCCCC | 54.43 | 26822725 | |
| 43 | 2-Hydroxyisobutyrylation | TVKLAKHKELAPYDE HHHHHHCCCCCCCCC | 54.43 | - | |
| 43 | Ubiquitination | TVKLAKHKELAPYDE HHHHHHCCCCCCCCC | 54.43 | 21906983 | |
| 48 | Phosphorylation | KHKELAPYDENWFYT HCCCCCCCCCCCCHH | 30.22 | 28152594 | |
| 54 | Phosphorylation | PYDENWFYTRAASTA CCCCCCCHHHHHHHC | 6.22 | 20860994 | |
| 55 | Phosphorylation | YDENWFYTRAASTAR CCCCCCHHHHHHHCC | 12.35 | 20860994 | |
| 56 | Methylation | DENWFYTRAASTARH CCCCCHHHHHHHCCH | 19.44 | 115492543 | |
| 59 | Phosphorylation | WFYTRAASTARHLYL CCHHHHHHHCCHHHH | 22.93 | 19200342 | |
| 60 | Phosphorylation | FYTRAASTARHLYLR CHHHHHHHCCHHHHC | 24.00 | 22210691 | |
| 65 | Phosphorylation | ASTARHLYLRGGAGV HHHCCHHHHCCCCCC | 6.55 | 22210691 | |
| 67 | Methylation | TARHLYLRGGAGVGS HCCHHHHCCCCCCCC | 28.13 | 24129315 | |
| 74 | Phosphorylation | RGGAGVGSMTKIYGG CCCCCCCCCCEEECC | 22.37 | 20068231 | |
| 75 | Sulfoxidation | GGAGVGSMTKIYGGR CCCCCCCCCEEECCC | 3.49 | 30846556 | |
| 76 | Phosphorylation | GAGVGSMTKIYGGRQ CCCCCCCCEEECCCC | 18.91 | 28985074 | |
| 77 | Acetylation | AGVGSMTKIYGGRQR CCCCCCCEEECCCCC | 25.86 | 19608861 | |
| 77 | Ubiquitination | AGVGSMTKIYGGRQR CCCCCCCEEECCCCC | 25.86 | 21906983 | |
| 77 | 2-Hydroxyisobutyrylation | AGVGSMTKIYGGRQR CCCCCCCEEECCCCC | 25.86 | - | |
| 88 | Sulfoxidation | GRQRNGVMPSHFSRG CCCCCCCCCCCCCCC | 2.74 | 21406390 | |
| 90 | Phosphorylation | QRNGVMPSHFSRGSK CCCCCCCCCCCCCCH | 21.04 | 26434776 | |
| 93 | Phosphorylation | GVMPSHFSRGSKSVA CCCCCCCCCCCHHHH | 30.24 | 26434776 | |
| 94 | Methylation | VMPSHFSRGSKSVAR CCCCCCCCCCHHHHH | 53.08 | 115492551 | |
| 96 | Phosphorylation | PSHFSRGSKSVARRV CCCCCCCCHHHHHHH | 22.20 | 26434776 | |
| 98 | Phosphorylation | HFSRGSKSVARRVLQ CCCCCCHHHHHHHHH | 23.78 | 29514088 | |
| 111 | Acetylation | LQALEGLKMVEKDQD HHHHHHHCCEEECCC | 52.32 | 19608861 | |
| 111 | 2-Hydroxyisobutyrylation | LQALEGLKMVEKDQD HHHHHHHCCEEECCC | 52.32 | - | |
| 111 | Ubiquitination | LQALEGLKMVEKDQD HHHHHHHCCEEECCC | 52.32 | 21906983 | |
| 112 | Sulfoxidation | QALEGLKMVEKDQDG HHHHHHCCEEECCCC | 5.90 | 28183972 | |
| 115 | Acetylation | EGLKMVEKDQDGGRK HHHCCEEECCCCCCE | 49.64 | 25825284 | |
| 122 | 2-Hydroxyisobutyrylation | KDQDGGRKLTPQGQR ECCCCCCEECCCCHH | 61.05 | - | |
| 122 | Ubiquitination | KDQDGGRKLTPQGQR ECCCCCCEECCCCHH | 61.05 | - | |
| 133 | Methylation | QGQRDLDRIAGQVAA CCHHHHHHHHHHHHH | 28.14 | 115492535 | |
| 143 | 2-Hydroxyisobutyrylation | GQVAAANKKH----- HHHHHHHCCC----- | 47.71 | - | |
| 143 | Ubiquitination | GQVAAANKKH----- HHHHHHHCCC----- | 47.71 | - | |
| 143 | Succinylation | GQVAAANKKH----- HHHHHHHCCC----- | 47.71 | - | |
| 143 | Succinylation | GQVAAANKKH----- HHHHHHHCCC----- | 47.71 | - | |
| 143 | Acetylation | GQVAAANKKH----- HHHHHHHCCC----- | 47.71 | 25953088 | |
| 144 | Acetylation | QVAAANKKH------ HHHHHHCCC------ | 55.12 | 25953088 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RS19_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RS19_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 105650 | Diamond-Blackfan anemia 1 (DBA1) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-23; LYS-77 AND LYS-111, ANDMASS SPECTROMETRY. | |